Nexgel (NXGLW) Current Deferred Revenue (2020 - 2025)

Nexgel (NXGLW) has 5 years of Current Deferred Revenue data on file, last reported at $2000.0 in Q4 2025.

• Quarterly Current Deferred Revenue fell 98.88% year-over-year to $2000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2000.0 (down 98.88% YoY) and the FY2025 annual result came in at $2000.0, down 98.88% from the prior year.
• Current Deferred Revenue fell to $2000.0 in Q4 2025, from $180000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $286000.0 in Q1 2025 to a low of $2000.0 in Q4 2025.
• A 4-year average of $138818.2 and a median of $179000.0 in 2024 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2024 — Current Deferred Revenue surged 795.0% — and 2025, when it sank 98.88%.
• Tracing NXGLW's Current Deferred Revenue over 4 years: stood at $38000.0 in 2021, then slumped by 47.37% to $20000.0 in 2023, then soared by 795.0% to $179000.0 in 2024, then slumped by 98.88% to $2000.0 in 2025.
• The last three Current Deferred Revenue figures came in at $2000.0 (Q4 2025), $180000.0 (Q3 2025), and $180000.0 (Q2 2025), per Business Quant data.